AARTIDRUGS Intraday Analysis...

AARTIDRUGS Share Price

Open 579.70 Change Price %
High 583.95 1 Day 2.45 0.43
Low 570.00 1 Week -6.85 -1.18
Close 571.30 1 Month -37.70 -6.19
Volume 4028 1 Year 97.60 20.60
52 Week High 686.45
52 Week Low 431.60
AARTIDRUGS Important Levels
Resistance 2 584.23
Resistance 1 578.90
Pivot 575.08
Support 1 563.70
Support 2 558.37
NSE INDIA Most Active Stocks
SUZLON 18.35 -2.91%
JPASSOCIAT 13.05 -2.61%
BANKBARODA 172.30 1.92%
IDEA 87.60 -3.63%
SINTEX 104.25 4.41%
HINDALCO 188.70 -3.18%
PNB 147.25 4.06%
STAMPEDE 21.65 6.39%
SBIN 279.45 1.07%
RCOM 38.15 -1.29%
More..
NSE INDIA Top Gainers Stocks
FARMAXIND 0.10 100.00%
VKSPL 0.10 100.00%
KSERASERA 0.20 33.33%
ATNINTER 0.30 20.00%
KANANIIND 15.90 20.00%
ONELIFECAP 26.80 19.91%
KAUSHALYA 5.50 19.57%
LINCPEN 308.65 17.72%
BPL 73.35 15.24%
BPL 73.35 15.24%
More..
NSE INDIA Top Losers Stocks
PTL 56.45 -62.81%
PTL 56.45 -62.81%
RASOYPR 0.15 -25.00%
RAJRAYON 0.25 -16.67%
XLENERGY 2.55 -15.00%
BLUECHIP 0.30 -14.29%
INFIBEAM 1218.95 -11.63%
REISIXTEN 0.40 -11.11%
IOLCP 78.55 -11.09%
REFEX 20.90 -9.91%
More..

Aarti Drugs Limited (NSE: AARTIDRUGS)

AARTIDRUGS Technical Analysis 2
As on 27th Mar 2017 AARTIDRUGS Share Price closed @ 571.30 and we RECOMMEND Buy for LONG-TERM with Stoploss of 555.62 & Strong Sell for SHORT-TERM with Stoploss of 605.32 we also expect STOCK to react on Following IMPORTANT LEVELS.
AARTIDRUGS Target for March
1st Target up-side 630.33
2nd Target up-side 651.34
3rd Target up-side 672.35
1st Target down-side 570.38
2nd Target down-side 549.37
3rd Target down-side 528.36
AARTIDRUGS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 33.47 Sideways
MFI (14) MFI is 25.81 Sideways
CCI (20) CCI is -68.86 Sideways
WILLIAM %R (14) William %R is -78.11 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 591.08
10 Day Avg Volume Traded -72.56 % Less then 10 Day Average Volume
AARTIDRUGS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.aartidrugs.com
AARTIDRUGS Address
AARTIDRUGS
Mahendra Industrial Estate
Ground Floor
Mumbai, 400022
India
Phone: 91 22 2401 9025
Fax: 91 22 2407 3462
AARTIDRUGS Latest News
Aarti Drugs Ltd Fixes Record Date for 1:1 Bonus Issue   Equity Bulls   - 19th Mar 15
Aarti Drugs - Board Meeting on March 26, 2015   Moneycontrol.com   - 17th Mar 15
Newspapers Advertisement of Result of Postal Ballot   Hindu Business Line   - 16th Mar 15
Here are six things that you need to know about Aarti Drugs   Moneycontrol.com   - 16th Feb 15
Aarti Drugs hits new high on 1:1 bonus issue; strong Q3 results   Business Standard   - 02nd Feb 15
Aarti Drugs Board approves bonus issue   Indiainfoline   - 30th Jan 15
Aarti Drugs to consider second interim dividend   Moneycontrol.com   - 19th Jan 15
Buy Aarti Drugs; target of Rs 1031: Sunidhi Securities   Moneycontrol.com   - 12th Aug 14
Aarti Drugs eyes to buy a Baddi company for toll manufacturing   Business Standard   - 07th Jul 14
USFDA issues warning letter to Mumbai-based Aarti Drugs   Business Standard   - 25th Sep 13
Interactive Technical Analysis Chart Aarti Drugs Limited ( AARTIDRUGS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aarti Drugs Limited
AARTIDRUGS Business Profile
Aarti Drugs Limited was incorporated on 28th September, 1984 as a Private Limited Company and then it was converted into a Public Limited Company on 1st July, 1992.The Company has established a strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.The manufacturing-units of ADL are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all its units and one of the units has already been approved. Aarti Drugs has reported a standalone sales turnover of Rs 218.64 crore and a net profit of Rs 11.84 crore for the quarter ended June 2013. The registered office is at Plot No. N - 198, M.I.D.C., Tarapur, Village - Pamtembhi, Taluka - Palghar, District Thane - 401 506 in Maharashtra and Corporate office is at Mahendra Industrial Estate, Ground Floor, Road No 29, Plot No 109-D, SION, Mumbai.